MedPath

Detection of Urinary Human Chorionic Gonadotropin (hCG)

Recruiting
Conditions
Pregnancy Detection
Interventions
Device: Daily test with urine by the product
Registration Number
NCT05458778
Lead Sponsor
Quanovate Tech Inc.
Brief Summary

The Mira Pregnancy Test is an over-the-counter urine hCG test intended for early detection of pregnancy. The test is indicated for use four days before the expected period. Throughout this study, volunteers with non-medical backgrounds were recruited to test hCG with urine samples using the Mira Pregnancy Test during the not pregnancy cycle or pregnancy cycle. To perform the study, a total number of more than 200 volunteers will be recruited to participate in the study.

Detailed Description

The studies include two parts, which are a lay user study and a urine samples test during the trying to conceive cycle.

Part 1: Lay user study Part 2: Detection of hCG in Early Pregnancy Clinical Samples

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
200
Inclusion Criteria
  • Female
  • Aged 18 and over
  • Willing to give informed consent
  • Willing to conduct a personal home pregnancy test and reveal their pregnancy status
  • Have a working smartphone
Exclusion Criteria
  • Have a medical background or have been in a related industry/occupation
  • Volunteers who are unfit to participate in the research by the researcher
  • Used the investigational pregnancy test previously
  • Has a medical condition
  • Confirmed to be pregnant by a healthcare professional and beyond the first trimester (defined as last menstrual period (LMP) +13 weeks)

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Women who are trying to conceiveDaily test with urine by the product-
Primary Outcome Measures
NameTimeMethod
Cognitive evaluation via survey and calculating the consistencyFrom July 2022 to August 2022

The consistency between the lay-user test results and the actual test results

The accuracy of data was expressed as per the Pregnancy Detection RateFrom July 2022 to August 2022

The number of positive results on different days obtained by the user of the Mira pregnancy test is divided by the total number of women who confirmed pregnancy.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Quanovate Tech Inc.

🇺🇸

San Ramon, California, United States

© Copyright 2025. All Rights Reserved by MedPath